The 2022 Chinese Pharmaceutical Association Pharmaceutical Bioanalysis Society (hereinafter referred to as CBF) was officially held on June 17. The venue was divided into a main venue and three sub-venues: DMPK sub-venue, bioanalysis sub-venue and biomarker sub-venue. From 13:30 to 14:00 on June 19, Dr. Li Zhiyan, Director of Bioanalysis of Xihua Biopharmaceuticals, will give a keynote report on "Bioanalysis Strategies of AAV Gene Therapy Drugs" at the bioanalysis venue.